From: Influence of automated visual field testing on intraocular pressure
Patients (n = 95) | ||
---|---|---|
Age in years (mean ± SD) | 67 ± 12 | |
Sex | Male 47 (49.5%) | Female 48 (50.5%) |
Number of eyes using glaucoma medication | 83 (87.4%) | |
1 glaucoma medication | 40 (42.1%) | |
2 glaucoma medication | 33 (34.7%) | |
3 glaucoma medication | 9 (9.5%) | |
4 glaucoma medication | 1 (1.1%) | |
Glaucoma surgery (in right eyes) | 12 (12.6%) | |
Central corneal thickness (μm, mean ± SD, range) | 544 ± 39 (439 to 648) | |
VF test duration (min, mean ± SD, range) | 9,6 ± 2,9 (4 to 17) | |
Mean Deviation (dB, mean ± SD) | −5.8 ± 7.04 | |
Primary open angle glaucoma | 74 (77.9%) | |
Chronic angle closure glaucoma | 13 (13.7%) | |
Ocular hypertension | 8 (8.4%) | |
Types of VF test | ||
HFA 24–2 + 10–2 | 56 (58,9%) | |
HFA 24–2 | 14 (14,7%) | |
HFA 10–2 | 2 (2,1%) | |
FDT + HFA 24–2 | 13 (13,7%) | |
Octopus G2 + C08 | 8 (8,4%) | |
Octopus G2 | 1 (1,1%) | |
FDT | 1 (1,1%) |